Magenta Therapeutics, Inc.
ANTI-CD45 ANTIBODIES AND CONJUGATES THEREOF
Last updated:
Abstract:
Disclosed are anti-CD45 antibodies and antibody drug conjugates (ADCs) useful in therapeutic methods, including targeting CD45 expressing hematopoietic stem cells (HSCs) or immune cells prior to transplantation.
Status:
Application
Type:
Utility
Filling date:
29 Apr 2021
Issue date:
2 Dec 2021